This paper examines the effects of morpheme boundaries on intergestural timing, and demonstrates that low-level phonetic realization is influenced by morphological structure, i.e. compounding and affixation. It reports two experiments, one using electromagnetic midsagittal articulography (EMA) and one electropalatography (EPG), examining Korean data. The results of the EMA study show that intergestural timing is less variable for adjacent gestures across the word boundary inside a lexicalized compound than inside a nonlexicalized compound, and inside a monomorphemic word than across a morpheme boundary. The EPG study (which examined the timing in palatalization of a coronal) shows that both [ti] and [ni] have more variability in gestural timing when heteromorphemic than when tautomorphemic. Furthermore, the phonetic details of gestural overlap shed light on the asymmetry on palatalization between tautomorphemic and heteromorphemic gestural sequences (e.g. ni vs. n-i), presumably driven by paradigmatic contrast and preference of overlap. In short, what emerges from two experiments is that gestures are coordinated more stably within a single lexical item (a morpheme or a lexicalized compound) than across a boundary between lexical items. In accounting for the stability of intergestural timing within a lexical entry, several hypotheses were discussed including the Phase Window, Bonding Strength, Phonological Timing and Extended Phase Window model newly proposed here. The implication is that the morphological structure may be encoded in the phonetic realization, as is the case with other linguistic structure (e.g. prosodic structure).

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.